Skip to Main Content

Paper Details

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.
Cell Death Dis
40
2020
ABT-263, BCLXL, BIM, MCL1, MIK655, MIK665, NOXA, Navitoclax, S63845, S64315, anti-apoptotic BCL2 family members, cell lines, leukemia, melanoma, melanoma cells, melanomas, metastatic melanoma, mouse, patients, tumor
Author NameAffiliation
William A RobinsonUniversity of Colorado Anschutz Medical Campus
William A RobinsonUniversity of Colorado Anschutz Medical Campus
Aik Choon TanUniversity of Colorado Anschutz Medical Campus
Aik Choon TanMoffitt Cancer Center
Aik Choon TanUniversity of Colorado Anschutz Medical Campus
Aik Choon TanMoffitt Cancer Center
  • 1 - 6

Datasets

Release 1.2